- Home
- NAMS vs BDJ Comparison
NAMS vs BDJ Comparison
Compare NAMS & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- BDJ
- Stock Information
- Founded
- NAMS 2019
- BDJ 2005
- Country
- NAMS Netherlands
- BDJ United States
- Employees
- NAMS N/A
- BDJ N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- BDJ Finance Companies
- Sector
- NAMS Health Care
- BDJ Finance
- Exchange
- NAMS Nasdaq
- BDJ Nasdaq
- Market Cap
- NAMS 1.7B
- BDJ 1.6B
- IPO Year
- NAMS N/A
- BDJ N/A
- Fundamental
- Price
- NAMS $25.50
- BDJ $8.21
- Analyst Decision
- NAMS Strong Buy
- BDJ
- Analyst Count
- NAMS 6
- BDJ 0
- Target Price
- NAMS $36.20
- BDJ N/A
- AVG Volume (30 Days)
- NAMS 1.4M
- BDJ 561.6K
- Earning Date
- NAMS 02-06-2025
- BDJ 01-01-0001
- Dividend Yield
- NAMS N/A
- BDJ 8.85%
- EPS Growth
- NAMS N/A
- BDJ N/A
- EPS
- NAMS N/A
- BDJ N/A
- Revenue
- NAMS $33,594,000.00
- BDJ N/A
- Revenue This Year
- NAMS $129.49
- BDJ N/A
- Revenue Next Year
- NAMS N/A
- BDJ N/A
- P/E Ratio
- NAMS N/A
- BDJ N/A
- Revenue Growth
- NAMS 78.77
- BDJ N/A
- 52 Week Low
- NAMS $10.50
- BDJ $6.91
- 52 Week High
- NAMS $27.29
- BDJ $8.66
- Technical
- Relative Strength Index (RSI)
- NAMS 62.30
- BDJ 21.65
- Support Level
- NAMS $24.40
- BDJ $8.06
- Resistance Level
- NAMS $26.95
- BDJ $8.71
- Average True Range (ATR)
- NAMS 1.66
- BDJ 0.12
- MACD
- NAMS 0.41
- BDJ -0.08
- Stochastic Oscillator
- NAMS 81.51
- BDJ 7.22
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.